Epizyme To Present At Upcoming Conferences In May

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapeutics for cancer patients, today announced its participation in two upcoming conferences in May:

•Mizuho Healthcare Corporate Access Day at the Omni Berkshire Place Hotel in New York on Tuesday, May 5. Company management will participate in 1x1 meetings.

Help employers find you! Check out all the jobs and post your resume.

Back to news